American Society of Hematology


ASH regularly hosts educational webinars that feature presentations by experts in the field, cover current information on how to best diagnose and care for patients, and provide time for speakers and participants to discuss relevant issues during a question-and-answer session.

ASH webinars are offered live and recordings are archived on ASH On Demand.

CME credit is available for certain webinars where indicated. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive credit or a participation certificate, participants must complete a CME Evaluation Module.

Previous Webinars

Release DateTopic
January 30 , 2019Developing Multiple Choice Questions and Tests
April 18, 2018Converting Teaching into Educational Scholarship through Publishing
April 5, 2018Clinical Research Training Institute Mentorship Program
April 5, 2018Promoting Faculty Well Being in an Academic Health Center
November 13, 20175 Steps to MIPS Registry Reporting for Hematologists
September 21, 2017Coding for Sickle Cell Disease
September 5, 2017ASH Preview of the 2017 Meeting on Hematologic Malignancies: Focus on Myeloproliferative Neoplams/CML
July 31, 2017How to Develop a CV
June 16, 2017Treating AML: Current and Novel Approaches (ASH-LLS)
January 11, 2017 ASH Preview of the Meeting on Hematologic Malignancies: Focus on Myeloma
November 15, 2016 MACRA 101 for Hematologists
November 3, 2016 ASH Preview of the 2017 Meeting on Hematologic Malignancies: Focus on Lymphoma
August 31, 2016 ASH Presents an Exclusive Preview of the 2016 Meeting on Hematologic Malignancies
August 9, 2016 ASH-FDA Update on Nivolumab
July 29, 2016 ASH-FDA Update on Venetoclax
June 29, 2016 ASH-FDA Update on Ixazomib
June 17, 2016 ASH-FDA Update on Daratumumab
May 18, 2016 ASH-FDA Update on Idarucizumab
May 16, 2016 ASH-FDA Update on von Willebrand factor (Recombinant)
March 14, 2016 ASH-FDA Update on Elotuzumab
February 11, 2016 ASH-FDA Update on Eltrombopag for Treatment of Children with Chronic Immune Thrombocytopenia (ITP)
September 24, 2015 Optimization of Hydroxyurea for the Management of Sickle Cell Disease
June 24, 2015ASH Webinar on Panobinostat
June 24, 2015ASH Webinar on Blinatumomab
May 20, 2015  The Direct Oral Anti-coagulants and Recent Approval of Edoxaban
April 22, 2015 Chimeric T-Cell Antigen Receptor Therapy in Leukemia and Lymphoma
April 9, 2015 The Medicare Oncology Care Model: What it Is and What it Means for Practice
February 4, 2015 Choosing Wisely: Examples of Stewardship Initiatives in Hematology
January 21, 2015Meet the Professor: The Research Question and Building Research Infrastructure
September 29, 2014 ASH-FDA Update on: Idelalisib for Treatment of CLL, FL, and SLL
September 26, 2014ASH-FDA Update on: Belinostat for Treatment of Peripheral T-cell Lymphoma
September 22, 2014Recent FDA-Approved Therapies for Hemophilia A and B
May 9, 2014ASH-FDA Update on: Ibrutinib for Treatment of Chronic Lymphocytic Lymphoma
back to top